Rifampin Tablets
Intended to mitigate bacterial load, to target tuberculosis infection.
- Category
- Antibiotics
- Active ingredient
- Rifampicin
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Tablet
- Strengths
- 150 · 300 · 450 · 600mg
Rifampin Tablets details
- Conditions
- Tuberculosis · Meningococcal Carriage
- Alternative names
- Rifadin; Rimactane
- Therapeutic class
- Rifamycin Antibiotic
- Pharmacological class
- Rifamycin
- Contraindications
- hypersensitivity to rifamycins; jaundice; concurrent use of certain antivirals
- Minor side effects
- nausea; diarrhoea; red-orange body fluids
- Moderate side effects
- hepatotoxicity
- Dosage forms
- Tablet
- Administration route
- Oral use
- Patient summary
- intended to mitigate bacterial load, to target tuberculosis infection.
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Sanofi
- Onset Time
- 2–4 hours
- Duration
- 8–12 hours
- Storage instructions
- Store in a cool, dry place.
- Drug interactions
- oral contraceptives; warfarin; corticosteroids; antifungals
- Age restrictions
- Safe for use in children with appropriate weight-based dosage.
Precautions and warnings
may cause orange discoloration of urine and fluids; liver function monitoring required; avoid soft contact lenses
Serious side effects
anaphylaxis, requires immediate medical attention; acute renal failure, requires immediate medical attention
Mechanism of action
Rifampicin inhibits bacterial ribonucleic acid polymerase, thereby suppressing deoxyribonucleic acid-dependent ribonucleic acid synthesis and causing bacterial cell death.
Pregnancy and breastfeeding
Pregnancy: Use only if essential. Breastfeeding: Present in breast milk; monitor infant.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Rifampin Tablets
Rifampin Tablets contain the active ingredient rifampicin, a broad-spectrum antibiotic used in the treatment of tuberculosis and the reduction of meningococcal carriage. This ingredient is also found in brands like Rifadin and Rimactane. Produced by manufacturers such as Sanofi, Rifampin Tablets are supplied in 150mg, 300mg, 450mg, and 600mg strengths.
Rifampin Tablets availability in Asia
Rifampin Tablets are registered across 14 markets, including the Philippines, Indonesia and Taiwan, with access also available in South Korea, Japan and the UAE. Generic rifampicin, often produced in India, serves as an economical alternative to the original brand for people living throughout these areas. As this medication is used for serious health conditions, it is best used under the specific care of a medical professional.